INS and diabetes mellitus: This study has shown improved glycaemic control in patients with pre‐existing diabetes mellitus, illustrated by gradual reduction in insulin dose and oral anti‐glycaemic agent requirement in the months post‐transplant, with reduction in HbA1c.